Robeco Institutional Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-33,021
Closed -$3.82M 1146
2023
Q3
$3.82M Hold
33,021
0.01% 592
2023
Q2
$3.4M Hold
33,021
0.01% 607
2023
Q1
$3.6M Sell
33,021
-9,301
-22% -$1.03M 0.01% 612
2022
Q4
$4.82M Sell
42,322
-7,761
-15% -$645K 0.01% 575
2022
Q3
$3.1M Buy
50,083
+3,097
+7% +$216K 0.01% 589
2022
Q2
$3.75M Buy
46,986
+40,725
+650% +$3.86M 0.01% 562
2022
Q1
$660K Sell
6,261
-28,267
-82% -$2.75M ﹤0.01% 744
2021
Q4
$3.72M Buy
34,528
+12,381
+56% +$1.35M 0.01% 583
2021
Q3
$2.43M Sell
22,147
-26,051
-54% -$2.7M 0.01% 640
2021
Q2
$4.51M Sell
48,198
-747
-2% -$68.7K 0.01% 592
2021
Q1
$4.51M Sell
48,945
-5,016
-9% -$423K 0.01% 572
2020
Q4
$3.95M Buy
53,961
+50,727
+1,569% +$3.77M 0.01% 583
2020
Q3
$251K Buy
+3,234
New +$223K ﹤0.01% 822
2018
Q4
Sell
-10,124
Closed -$198K 1013
2018
Q3
$198K Sell
10,124
-4,013
-28% -$76.3K ﹤0.01% 908
2018
Q2
$234K Buy
+14,137
New +$216K ﹤0.01% 891

Other funds holding HZNP